Aro Biotherapeutics

Developer of tissue-targeted genetic medicines for rare diseases

placePhiladelphia, Pennsylvania, United States calendar_todayFounded 2018 groups47 employees language arobiotx.com

Registered entities

Innovation

16 patent families (6 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace steady. Cited 3,128 times.

YearFilings
20215
20225
202310
20249
202512
20262

Social engagement

Social engagement: 7.6K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

9 investors on record; lead investors include Cowen, Northpond Ventures.

Investor typeCountShare
Venture capital222%
Private equity333%
Bank & private debt111%
Other / undisclosed333%

Hiring activity

Hires periodically

4 roles tracked across 3 of the last 12 months

1 Apr 2026 · Facilities & Office Support Coordinator · Philadelphia, Pennsylvania

20 Mar 2026 · Scientist II, Immunology · Philadelphia, Pennsylvania

17 Mar 2026 · Post-Doctoral Scientist, Nucleic Acid Chemistry · Philadelphia, Pennsylvania

7 Nov 2025 · Scientist, Bioconjugation · Philadelphia, Pennsylvania

26 Oct 2025 · Senior/Principal Investigator, Protein Sciences · Philadelphia, Pennsylvania

Based on job postings tracked across public sources.

Recent activity

17 Mar 2026
Milestone
regulatory
Coming soon